“…Age, tumor-brain interface, tumor enhancement, brain edema, and tumor location were significantly different between patients with benign meningiomas and those with high-grade meningiomas. According to the results of multivariate logistic regression analysis, age ≥ 75 years, unclear tumor-brain interface, and heterogeneous tumor enhancement were strong independent predictive factors, with ORs of 4.28 (95% confidence interval [CI] 1.14-16.10; p = 0.0314), 16.55 (95% CI 2.23-122.85; p = 0.0061), and 4.39 (95% CI 1.26-15.33; p = 0.0204), respectively ( Table 2). There was a negative correlation between unclear tumor-brain interface and positive capsular enhancement (OR 0.1; p = 0.001, data not shown).…”